Held, Claes <br/><br/>
Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial.  [electronic resource] 

 -  American heart journal  02 2019 
 - 65-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-6744 
<br/><br/><label>Standard No.: </label>10.1016/j.ahj.2018.10.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angina, Unstable--epidemiology<br/>Benzaldehydes--therapeutic use<br/>Coronary Disease--complications<br/>Endpoint Determination<br/>Heart Failure--epidemiology<br/>Hospitalization--statistics & numerical data<br/>Humans<br/>Ischemic Attack, Transient--epidemiology<br/>Kaplan-Meier Estimate<br/>Myocardial Infarction--epidemiology<br/>Oximes--therapeutic use<br/>Percutaneous Coronary Intervention--statistics & numerical data<br/>Phospholipase A2 Inhibitors--therapeutic use<br/>Placebos--therapeutic use<br/>Stroke--epidemiology